Cargando…

WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells

SIMPLE SUMMARY: Patients with advanced intrahepatic cholangiocarcinoma (iCCA) have a very poor prognosis, and no targeted therapy is approved for advanced iCCA. A therapeutic strategy for wild-type p53 cancers is the reactivation of p53 by inhibition of its the negative regulators, MDM2, and WIP1. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chiao-En, Huang, Chen-Yang, Chen, Chiao-Ping, Pan, Yi-Ru, Chang, John Wen-Cheng, Chen, Jen-Shi, Yeh, Chun-Nan, Lunec, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345393/ https://www.ncbi.nlm.nih.gov/pubmed/34359777 http://dx.doi.org/10.3390/cancers13153876

Ejemplares similares

Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis
por: Chen, Zhenghu, et al.
Publicado: (2016)

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma
por: Wu, Chiao-En, et al.
Publicado: (2018)

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
por: Wu, Chiao-En, et al.
Publicado: (2020)

p53 as a biomarker and potential target in gastrointestinal stromal tumors
por: Wu, Chiao-En, et al.
Publicado: (2022)

Tipping Growth Inhibition into Apoptosis by Combining Treatment with MDM2 and WIP1 Inhibitors in p53(WT) Uterine Leiomyosarcoma
por: Chamberlain, Victoria, et al.
Publicado: (2021)

The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
por: Kojima, Kensuke, et al.
Publicado: (2016)

ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma
por: Wu, Chiao-En, et al.
Publicado: (2018)

TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response
por: Wu, Chiao-En, et al.
Publicado: (2019)

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
por: Stein, Eytan M., et al.
Publicado: (2022)

Tyrosine phosphorylation of WIP releases bound WASP and impairs podosome assembly in macrophages
por: Vijayakumar, Vineetha, et al.
Publicado: (2015)

Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis
por: Zane, Linda, et al.
Publicado: (2012)

Wip1 phosphatase: between p53 and MAPK kinases pathways
por: Goloudina, Anastasia R., et al.
Publicado: (2016)

Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
por: Castellino, Robert C., et al.
Publicado: (2007)

5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2()
por: Dickens, Michael P., et al.
Publicado: (2013)

MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
por: Seipel, Katja, et al.
Publicado: (2018)

Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26
por: Zhang, Ying, et al.
Publicado: (2010)

The Expression and Function of NUMB in Endometrial Cancer and the Interaction with HDM2 and P53
por: Wang, Chao, et al.
Publicado: (2015)

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
por: Pan, Yi-Ru, et al.
Publicado: (2020)

WIP Remodeling Actin behind the Scenes: How WIP Reshapes Immune and Other Functions
por: Noy, Elad, et al.
Publicado: (2012)

Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function
por: Uhrik, Lukas, et al.
Publicado: (2019)

Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53
por: Heminger, Katherine, et al.
Publicado: (2009)

Modulation of LSD1 phosphorylation by CK2/WIP1 regulates RNF168-dependent 53BP1 recruitment in response to DNA damage
por: Peng, Bin, et al.
Publicado: (2015)

Oligobenzamide proteomimetic inhibitors of the p53–hDM2 protein–protein interaction
por: Plante, Jeffrey P., et al.
Publicado: (2009)

Effect of linker on the binding free energy of stapled p53/HDM2 complex
por: Im, Haeri, et al.
Publicado: (2020)

Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds
por: Liu, Li-Juan, et al.
Publicado: (2016)

Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase
por: Shreeram, Sathyavageeswaran, et al.
Publicado: (2006)

Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity
por: Sriraman, Anusha, et al.
Publicado: (2016)

Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression
por: Wang, J, et al.
Publicado: (2016)

Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
por: Liu, Qingjun, et al.
Publicado: (2011)

Searches for 2HDM at the LHC
por: Chakraborty, Dhiman
Publicado: (2014)

HDM2 ERKs PCNA
por: Nguyen, Hai Dang, et al.
Publicado: (2010)

Searches for 2HDM at the LHC
por: Koehlmann, S
Publicado: (2013)

A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphism
por: Bond, GL, et al.
Publicado: (2005)

Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
por: Wu, Chiao-En, et al.
Publicado: (2020)

Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
por: Wu, Chiao-En, et al.
Publicado: (2021)

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
por: Fischer, Peter M.
Publicado: (2006)

Activity‐Directed Synthesis of Inhibitors of the p53/hDM2 Protein–Protein Interaction
por: Green, Adam I., et al.
Publicado: (2020)

WIP1 and senescence: Oxygen matters
por: Olcina, Monica M, et al.
Publicado: (2014)

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
por: Pan, Yi-Ru, et al.
Publicado: (2020)

Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma
por: Tsai, Chia-Lung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_62us61qek3754oo73vbhho5b9k